LIMITATIONS OF A PORTABLE INFUSION PUMP IN AMBULATORY PATIENTS RECEIVING CONTINUOUS INFUSIONS OF ANTI-CANCER DRUGS

  • 1 January 1979
    • journal article
    • research article
    • Vol. 63  (2) , 211-213
Abstract
The delivery of continuous i.v. bleomycin and 5-fluorouracil to 9 ambulatory cancer patients was studied using a novel disposable portable infusion pump, the Ar/Med Infusor. Although the chemotherapy was satisfactorily delivered, there were significant mechanical problems, including variable flow rates and substantial drug cartridge failure. Most therapy courses were finished within 10% of the projected termination time. Serious venous complications did not occur. While further exploration of various devices for outpatient continuous i.v. therapy is recommended, technical improvements are probably needed for the Ar/Med Infusor.

This publication has 1 reference indexed in Scilit: